BNN BRAIN Biotech AG

2.890EUR0.00%Mkt Cap: 68.63M $P/E: —

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubato…

Key Statistics

Company
Market Cap68.63M USD
Enterprise Value67.61M USD
Revenue (TTM)50.08M USD
Gross Profit31.13M USD
Net Income (TTM)-12.76M USD
Revenue/Share2.11 EUR
Last Price2.890 EUR
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees280
CountryDE
SectorBasic Materials
IndustrySpecialty Chemicals
ISINDE0005203947
Valuation
P/E (Trailing)—
P/E (Forward)-7.23
PEG—
EV/EBITDA-12.09
EV/Revenue1.35
P/S1.37
P/B-8.87
EPS (TTM)-0.64
EPS (Forward)-0.40
52W Range
2.05050% of range3.740
52W High3.740 EUR
52W Low2.050 EUR
Profitability
Gross Margin57.26%
Oper. Margin-19.96%
EBITDA Margin-11.17%
Profit Margin-23.48%
ROE-637.81%
ROA-17.70%
Growth
Revenue Growth-16.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.04M USD
CapEx (TTM)1.75M USD
FCF Margin-0.85%
FCF Yield-0.62%
Net Debt-1.02M USD
Net Debt/EBITDA0.18
Balance Sheet
Debt/Equity4.64
Current Ratio1.34
Quick Ratio0.06
Book Value/Sh-0.33 EUR
Cash/Share0.04 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.750 EUR
Upside (mean)+99.0%
Target Range5.000 EUR – 6.500 EUR
5.000+99.0% to mean6.500
# Analysts2
Ownership
Shares Out.21.85M
Float9.09M
Insiders58.40%
Institutions8.49%
Technical
SMA 502.793 (+3.5%)
SMA 2002.678 (+7.9%)
Beta0.62
S&P 52W Chg14.58%
Avg Vol (30d)6.68K
Avg Vol (10d)4.89K
Technical Indicators
RSI (14)55.7
MACD0.0214
MACD Signal0.0137
MACD Hist.+0.0076
BB Upper2.974 EUR
BB Middle2.818 EUR
BB Lower2.663 EUR
BB Width11.02%
ATR (14)0.1467 EUR
Vol Ratio (20d)0.65x